Calithera: Special meeting for purpose of voting on dissolution cancelled

Calithera Bioscience announced that it was unable to achieve a quorum of stockholders at its special meeting of stockholders scheduled to be held on June 29 or the purpose of approving the Company’s Plan of Complete Liquidation and Dissolution. In January 2023, the Company announced its intention to commence an orderly wind down of the Company’s business and operations. After consulting with its proxy solicitation advisors, the Company concluded that further attempts to solicit proxies for the Special Meeting would in all likelihood not allow it to achieve a quorum, and as a result has cancelled.